| scholarly article | Q13442814 |
| P2093 | author name string | Fang Wang | |
| Wei-Hua Jia | |||
| Xiao-Hui Zheng | |||
| Xi-Zhao Li | |||
| Shao-Yi Huang | |||
| Jiang-Bo Zhang | |||
| Yong-Qiao He | |||
| Si-Qi Dong | |||
| Tong-Min Wang | |||
| Mu Jianbing | |||
| P2860 | cites work | Epstein-Barr Virus Strain Variation | Q38596335 |
| Epstein-Barr Virus Lytic Cycle Reactivation | Q38597247 | ||
| Epstein-Barr virus strains and variations: Geographic or disease-specific variants? | Q38901360 | ||
| Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients | Q39040021 | ||
| An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation | Q39279923 | ||
| Immediate-early transactivator Rta of Epstein-Barr virus (EBV) shows multiple epitopes recognized by EBV-specific cytotoxic T lymphocytes | Q39581864 | ||
| Polymorphisms of Epstein-Barr virus BHRF1 gene, a homologue of bcl-2. | Q39626347 | ||
| Epstein-Barr virus infection and nasopharyngeal carcinoma | Q40046633 | ||
| Comparative analysis of 22 Epstein-Barr virus genomes from diseased and healthy individuals | Q40390418 | ||
| Identification of CD8+ T-cell epitopes specific for immediate-early transactivator Rta of Epstein-Barr virus | Q40413587 | ||
| Geographic Population Structure in Epstein-Barr Virus Revealed by Comparative Genomics | Q40446900 | ||
| Transcriptional expression of RPMS1 in nasopharyngeal carcinoma and its oncogenic potential. | Q40455582 | ||
| Characterization of Epstein-Barr virus gp350/220 gene variants in virus isolates from gastric carcinoma and nasopharyngeal carcinoma | Q45362064 | ||
| The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene | Q45387202 | ||
| Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein | Q45419685 | ||
| Re: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus | Q45722745 | ||
| Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus | Q45729956 | ||
| Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. | Q45734371 | ||
| Epidemiology of nasopharyngeal carcinoma. | Q45948135 | ||
| Recurrent chemical reactivations of EBV promotes genome instability and enhances tumor progression of nasopharyngeal carcinoma cells. | Q46170131 | ||
| New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China | Q46378710 | ||
| A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection | Q56355742 | ||
| From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes | Q26765442 | ||
| Epstein-barr virus sequence variation-biology and disease | Q27003183 | ||
| Regulation of the latent-lytic switch in Epstein-Barr virus | Q27021366 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci | Q28943422 | ||
| Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches | Q29036707 | ||
| Detecting the number of clusters of individuals using the software STRUCTURE: a simulation study | Q29547289 | ||
| Inferring weak population structure with the assistance of sample group information | Q29614777 | ||
| Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response | Q30442835 | ||
| Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma | Q33248430 | ||
| Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China | Q33248972 | ||
| Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites | Q33851925 | ||
| Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA. | Q33907682 | ||
| Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma | Q34173615 | ||
| Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient | Q34228526 | ||
| Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. | Q34262322 | ||
| Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. | Q34271121 | ||
| Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas | Q34410536 | ||
| ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus | Q34461528 | ||
| LMP1 strain variants: biological and molecular properties. | Q34717145 | ||
| Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma | Q35008890 | ||
| Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology | Q35363383 | ||
| Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection | Q35641421 | ||
| Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells | Q35797164 | ||
| The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter | Q35839977 | ||
| The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter. | Q35881644 | ||
| Genome-wide analysis of Epstein-Barr virus Rta DNA binding | Q35943838 | ||
| Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China | Q36092875 | ||
| Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication | Q36559479 | ||
| Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors | Q37485717 | ||
| The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal | Q37549340 | ||
| The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). | Q37976235 | ||
| Non-viral environmental risk factors for nasopharyngeal carcinoma: a systematic review | Q37981949 | ||
| Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma | Q37982181 | ||
| The pathological roles of BART miRNAs in nasopharyngeal carcinoma | Q37995110 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 101-109 | |
| P577 | publication date | 2018-11-09 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma | |
| P478 | volume | 37 |
Search more.